Up a level |
De Souza, Shuell, de Jong, Jeffrey Kahol, Perone, Ylenia, Shetty, Shishir, Qurashi, Maria, Vithayathil, Mathew, Shah, Tahir, Ross, Paul, Temperley, Laura, Yip, Vincent SS et al (show 9 more authors)
(2023)
Impact of COVID-19 on 1-Year Survival Outcomes in Hepatocellular Carcinoma: A Multicenter Cohort Study.
CANCERS, 15 (13).
3378-.
Sarker, Debashis, Plummer, Ruth, Meyer, Tim, Sodergren, Mikael H, Basu, Bristi, Chee, Cheng Ean, Huang, Kai-Wen, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Ting, Yuk, Evans, TR Jeff et al (show 26 more authors)
(2020)
MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-a, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial.
CLINICAL CANCER RESEARCH, 26 (15).
pp. 3936-3946.
Han, Guohong, Berhane, Sarah, Toyoda, Hidenori, Bettinger, Dominik, Elshaarawy, Omar, Chan, Anthony WH, Kirstein, Martha, Mosconi, Cristina, Hucke, Florian, Palmer, Daniel ORCID: 0000-0002-7147-5703 et al (show 24 more authors)
(2020)
Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach.
Hepatology (Baltimore, Md.), 72 (01).
pp. 198-212.
Hashimoto, Ayumi, Sarker, Debashis, Reebye, Vikash, Jarvis, Sheba, Sodergren, Mikael H, Kossenkov, Andrew, Sanseviero, Emilio, Raulf, Nina, Vasara, Jenni, Andrikakou, Pinelopi et al (show 21 more authors)
(2021)
Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer.
CLINICAL CANCER RESEARCH, 27 (21).
pp. 5961-5978.